After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Vertex Pharmaceuticals, Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Vertex Pharmaceuticals, Inc is $126.25B. A total of 1.15 million shares were traded on the day, compared to an average of 1.64M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, VRTX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, ALTSHULER DAVID sold 3,231 shares of VRTX for 490.00 per share on Mar 03 ’25. After the transaction, the EVP, Chief Scientific Officer now owns 29,743 company shares. In a previous transaction on Mar 04 ’25, Tatsis Ourania bought 4,058 shares at 485.49 per share.
Among the insiders who bought shares, ALTSHULER DAVID acquired of 3,231 shares on Mar 03 ’25 at a per-share price of $490.00. In another insider transaction, Tatsis Ourania sold 530 shares at $475.34 per share on Feb 27 ’25. Company shares held by the EVP, Chief Reg. & Quality Off. now total 58,539.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for VRTX in the last 3 months, the mean price target is $506.74 with high estimates of $615.00 and low estimates of $330.00. In terms of 52-week highs and lows, VRTX has a high of $519.88 and a low of $377.85.
As of this writing, VRTX has an earnings estimate of $4.31 per share for the current quarter. EPS was calculated based on a consensus of 22.0 estimates, with a high estimate of $5.19 per share and a lower estimate of $3.78.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VRTX’s latest balance sheet shows that the firm has $7.52B in Cash & Short Term Investments as of fiscal 2021. There were $967.40M in debt and $2.14B in liabilities at the time. Its Book Value Per Share was $63.87, while its Total Shareholder’s Equity was $10.10B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRTX is Buy with a score of 4.13.
